Active Biotech AB (publ) (ACTI.ST)

SEK 0.07

(-1.67%)

Long Term Debt Summary of Active Biotech AB (publ)

  • Active Biotech AB (publ)'s latest annual long term debt in 2023 was 3 Million SEK , down -32.31% from previous year.
  • Active Biotech AB (publ)'s latest quarterly long term debt in 2024 Q3 was - SEK , down 0.0% from previous quarter.
  • Active Biotech AB (publ) reported annual long term debt of 4.43 Million SEK in 2022, up 1861.06% from previous year.
  • Active Biotech AB (publ) reported annual long term debt of 226 Thousand SEK in 2021, down -67.2% from previous year.
  • Active Biotech AB (publ) reported quarterly long term debt of - SEK for 2024 Q3, down 0.0% from previous quarter.
  • Active Biotech AB (publ) reported quarterly long term debt of - SEK for 2024 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Active Biotech AB (publ) (2023 - 2002)

Historical Annual Long Term Debt of Active Biotech AB (publ) (2023 - 2002)

Year Long Term Debt Long Term Debt Growth
2023 3 Million SEK -32.31%
2022 4.43 Million SEK 1861.06%
2021 226 Thousand SEK -67.2%
2020 689 Thousand SEK -65.57%
2019 2 Million SEK 1824.04%
2018 104 Thousand SEK -64.98%
2017 297 Thousand SEK -99.86%
2016 206.95 Million SEK -4.31%
2015 216.27 Million SEK -2.86%
2014 222.63 Million SEK -0.63%
2013 224.04 Million SEK -1.94%
2012 228.47 Million SEK -2.69%
2011 234.79 Million SEK -2.84%
2010 241.67 Million SEK -2.54%
2009 247.95 Million SEK -1.5%
2008 251.72 Million SEK 1.33%
2007 248.41 Million SEK -2.53%
2006 254.85 Million SEK -28.16%
2005 354.73 Million SEK 260.24%
2004 98.47 Million SEK 1897.4%
2003 4.93 Million SEK 84.02%
2002 2.67 Million SEK 0.0%

Peer Long Term Debt Comparison of Active Biotech AB (publ)

Name Long Term Debt Long Term Debt Difference
Alzinova AB (publ) 800 Thousand SEK -275.0%
Amniotics AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK -200.0%
BioArctic AB (publ) 2.15 Million SEK -39.405%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 99.681%
Genovis AB (publ.) 74.8 Million SEK 95.99%
LIDDS AB (publ) - SEK -Infinity%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 90.792%
OncoZenge AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 95.401%
Simris Alg AB (publ) 90.74 Million SEK 96.694%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Camurus AB (publ) 13.61 Million SEK 77.962%
Cantargia AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK -252.941%
Kancera AB (publ) - SEK -Infinity%
Karolinska Development AB (publ) - SEK -Infinity%
Lipum AB (publ) 1.76 Million SEK -70.358%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xbrane Biopharma AB (publ) 112.89 Million SEK 97.343%
Xintela AB (publ) - SEK -Infinity%
Ziccum AB (publ) 286 Thousand SEK -948.951%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
Isofol Medical AB (publ) - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK 90.609%
CombiGene AB (publ) - SEK -Infinity%
Diamyd Medical AB (publ) 30.67 Million SEK 90.219%
Intervacc AB (publ) 142 Thousand SEK -2012.676%
Alligator Bioscience AB (publ) 7.51 Million SEK 60.085%
Sprint Bioscience AB (publ) - SEK -Infinity%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 24.51 Million SEK 87.761%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Biovica International AB (publ) 4.29 Million SEK 30.168%
Spago Nanomedical AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -607.547%
Egetis Therapeutics AB (publ) 103.4 Million SEK 97.099%
2cureX AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 844.9 Million SEK 99.645%
Cyxone AB (publ) 74 Thousand SEK -3954.054%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK -108.914%
Biosergen AB - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -2105.882%
SynAct Pharma AB 58 Thousand SEK -5072.414%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
BioInvent International AB (publ) 14.53 Million SEK 79.36%
Stayble Therapeutics AB (publ) 850 Thousand SEK -252.941%
Oncopeptides AB (publ) 106.48 Million SEK 97.183%
Pila Pharma AB (publ) - SEK -Infinity%
Ascelia Pharma AB (publ) 176 Thousand SEK -1604.545%
Diagonal Bio AB (publ) - SEK -Infinity%